Does Depth of Neuromuscular Blockade (NMB) Affect Surgical Conditions in Obese Patients Undergoing Robotic Surgery (NMB)
GYN Disorders, Urologic Diseases
About this trial
This is an interventional treatment trial for GYN Disorders focused on measuring Robotic Surgery
Eligibility Criteria
Inclusion Criteria:
- Patients scheduled for elective robotic gynecological or urologic surgery under general anesthesia.
- Patients are willing and sign an IRB approved consent
- Patients will be 18 years or older
Exclusion Criteria:
- Patients with atrial fibrillation
- Other significant arrhythmia (Lown grade 3 or greater)
- Patients with aortic regurgitation
- Unable to receive or refuses to usehydromorphone for pain management post-operatively (allergic, bad experience previously with use)
Sites / Locations
- University of Louisville Medical School, Department of Anesthesiology and Perioperative Medicine
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Deep NMB
Moderate NMB
Deep NMB: Intervention: Rocuronium will be given as a continuous infusion for deep block. TOF will be maintained at 0 (zero) with at least one PTC. Patients' paralysis will be continued through the anesthesia period. At the end of surgery, patients will receive 4 mg/kg sugammadex and the patient's trachea will be extubated according to routine extubation criteria.
Moderate NMB: Intervention: Rocuronium will be used as bolus doses to achieve a moderate block. TOF will be maintained between 1 to 3 twitches. PTC will not be counted. Paralysis will be continued throughout the anesthesia period. At the end of surgery, patients will receive 2 mg/kg sugammadex and the patient's trachea will be extubated according to routine extubation criteria.